Report
Louis-Clément AZAIS d'UHART
EUR 112.46 For Business Accounts Only

Short term view - ABBOTT LABORATORIES : The support has been breached.

In our previous short term analysis (19/10/2016), we were negative.
We remain negative with a target at 36,6 $ and an invalidation level at 41,53 $.
The bullish trend may be reversing to bearish.
Arguments :
- The support has been breached.
Underlying
Abbott Laboratories

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis-Clément AZAIS d'UHART

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch